Mapping the Influence of the Gut Microbiota on Small Molecules across the Microbiome Gut Brain Axis.
Heather HulmeLynsey M MeikleNicole StrittmatterJohn G SwalesGregory HammSheila L BrownSimon MillingAndrew S MacDonaldRichard J A GoodwinRichard J S BurchmoreDaniel M WallPublished in: Journal of the American Society for Mass Spectrometry (2022)
Microbes exert influence across the microbiome-gut-brain axis through neurotransmitter production, induction of host immunomodulators, or the release or induction of other microbial or host molecules. Here, we used mass spectrometry imaging (MSI), a label-free imaging tool, to map molecular changes in the gut and brain in germ-free, antibiotic-treated and control mice. We determined spatial distribution and relative quantification of neurotransmitters and their precursors in response to the microbiome. Using untargeted MSI, we detected a significant change in the levels of four identified small molecules in the brains of germ-free animals compared to controls. However, antibiotic treatment induced no significant changes in these same metabolites in the brain after 1 week of treatment. This work exemplifies the utility of MSI as a tool for the study of known and discovery of novel, mediators of microbiome-gut-brain axis communication.
Keyphrases
- resting state
- white matter
- mass spectrometry
- high resolution
- functional connectivity
- label free
- cerebral ischemia
- liquid chromatography
- ms ms
- multiple sclerosis
- microbial community
- type diabetes
- adipose tissue
- diabetic rats
- skeletal muscle
- metabolic syndrome
- oxidative stress
- endothelial cells
- blood brain barrier
- subarachnoid hemorrhage
- high performance liquid chromatography
- drug induced